Jiang Zhongkai,Fang Chunfeng,Li Lulu,et al.Dosimetric evaluation of intensity modulated proton therapy and photon volumetric modulated arc therapy for bilateral breast cancer[J].Chinese Journal of Radiological Medicine and Protection,2025,45(7):647-654
Dosimetric evaluation of intensity modulated proton therapy and photon volumetric modulated arc therapy for bilateral breast cancer
Received:July 16, 2024  
DOI:10.3760/cma.j.cn112271-20240716-00262
KeyWords:Bilateral breast cancer  Volumetric modulated arc therapy  Intensity modulated proton therapy  Plan quality
FundProject:
Author NameAffiliationE-mail
Jiang Zhongkai Department of Physics and Technology, Hebei Yizhou Tumor Hospital, Zhuozhou 072750, China  
Fang Chunfeng Department of Physics and Technology, Hebei Yizhou Tumor Hospital, Zhuozhou 072750, China  
Li Lulu Department of Radiation Oncology, Rizhao People's Hospital, Rizhao 276827, China  
Wang Zishen Department of Physics and Technology, Hebei Yizhou Tumor Hospital, Zhuozhou 072750, China  
Li Yumei Department of Physics and Technology, Hebei Yizhou Tumor Hospital, Zhuozhou 072750, China  
Xu Shouping Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China shouping_xu@yahoo.com 
Hits: 4906
Download times: 1062
Abstract::
      Objective To evaluate the dosimetric characteristics of intensity-modulated proton therapy (IMPT) and photon volumetric modulated arc therapy (VMAT) in radiation therapy planning for patients with bilateral breast cancer after breast-conserving surgery. Methods On the computed tomography localization images of 18 patients with bilateral breast cancer, target volumes and organs at risk were contoured to develop both IMPT and VMAT plans for each patient. Two IMPT plans were designed based on the clinical target volume (CTV) with robust optimization (RO-IMPT) and the planning target volume (PTV) without RO (NonRO-IMPT), respectively. The RO-IMPT, NonRO-IMPT, and VMAT plans were normalized such that the prescription dose could cover 95% of the target volume. The dosimetric parameters of target volumes and organs at risk were evaluated, and the dosimetric characteristics of the two techniques were compared. Results In terms of target volumes, the RO-IMPT group showed significantly lower D1%, Dmean, and homogeneity index (HI) and a significantly higher D99% of the CTV than those of the PTV in the VMAT group (t=-8.96, -8.21, -8.13, 4.96, P<0.05). The NonRO-IMPT group showed significantly lower D1%, Dmean, and HI and a significantly higher conformity index of the PTV than those of the PTV in the VMAT group (t=-7.75, -6.25, -6.11, 7.53, P<0.05). In terms of organs at risk, the two IMPT groups showed significantly lower values than the VMAT group for the V5-V30 and Dmean of the whole lungs, V5-V40 and Dmean of the heart, D1% and Dmean of the left anterior descending coronary artery, D1% of the spinal cord, Dmean of normal tissues, and Dmean of the skin (t= -28.47 to -3.25, P<0.05). There was no significant difference in any other evaluation indices (P>0.05). Conclusions Both IMPT and VMAT can meet the clinical requirements of radiotherapy plans following breast-conserving surgery for bilateral breast cancer. IMPT has apparent advantages over VMAT in protecting organs at risk.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:17875073  On-line:0

v
Scan QR Code
&et=8400690B225D0A44B78A0B7A1006E4B55F82552E5C42D1D22B98CB12A16D24214877A1A44DF49448D2EEC54F63B3B190E4426D523358579ACEE53B5C5CADF71D207245A69B60A13777CD01A3BE857CE31073D6375655EE84D0402AF8E4A2D750EFCF43C694A42BE810A23E5F5FAB690A065A2BC706F950817CAACCDA19A22B7C88359AA8F196C43A&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=E6A891D2134F30C0&aid=6F877BFB6D17052E0BF8A79470DDB89E&vid=&iid=DF92D298D3FF1E6E&sid=AEE2F90BC0DB5F35&eid=BBA8B1249CDAA6CE&fileno=20250704&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="E6A891D2134F30C0"; var my_aid="6F877BFB6D17052E0BF8A79470DDB89E";